X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs J.B.CHEMICALS - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE J.B.CHEMICALS CADILA HEALTHCARE/
J.B.CHEMICALS
 
P/E (TTM) x 13.3 17.3 76.5% View Chart
P/BV x 2.8 2.2 127.0% View Chart
Dividend Yield % 1.5 0.5 274.2%  

Financials

 CADILA HEALTHCARE   J.B.CHEMICALS
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
J.B.CHEMICALS
Mar-18
CADILA HEALTHCARE/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs558363 153.7%   
Low Rs362255 141.8%   
Sales per share (Unadj.) Rs116.3169.1 68.8%  
Earnings per share (Unadj.) Rs17.916.6 107.6%  
Cash flow per share (Unadj.) Rs23.123.4 98.8%  
Dividends per share (Unadj.) Rs3.502.00 175.0%  
Dividend yield (eoy) %0.80.6 117.6%  
Book value per share (Unadj.) Rs85.4172.5 49.5%  
Shares outstanding (eoy) m1,023.7483.57 1,225.0%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.01.8 216.4%   
Avg P/E ratio x25.718.6 138.2%  
P/CF ratio (eoy) x19.913.2 150.6%  
Price / Book Value ratio x5.41.8 300.4%  
Dividend payout %19.612.0 162.6%   
Avg Mkt Cap Rs m470,66425,827 1,822.4%   
No. of employees `00011.83.8 313.3%   
Total wages/salary Rs m18,5452,511 738.6%   
Avg. sales/employee Rs Th10,072.73,747.4 268.8%   
Avg. wages/employee Rs Th1,569.1665.7 235.7%   
Avg. net profit/employee Rs Th1,547.7367.8 420.8%   
INCOME DATA
Net Sales Rs m119,04914,135 842.2%  
Other income Rs m1,132366 309.5%   
Total revenues Rs m120,18114,501 828.8%   
Gross profit Rs m28,4752,178 1,307.2%  
Depreciation Rs m5,388570 945.8%   
Interest Rs m91135 2,610.3%   
Profit before tax Rs m23,3081,940 1,201.8%   
Minority Interest Rs m6280-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,644552 1,021.9%   
Profit after tax Rs m18,2921,387 1,318.6%  
Gross profit margin %23.915.4 155.2%  
Effective tax rate %24.228.5 85.0%   
Net profit margin %15.49.8 156.6%  
BALANCE SHEET DATA
Current assets Rs m82,00510,470 783.2%   
Current liabilities Rs m60,7202,749 2,208.8%   
Net working cap to sales %17.954.6 32.7%  
Current ratio x1.43.8 35.5%  
Inventory Days Days7355 132.5%  
Debtors Days Days9878 126.6%  
Net fixed assets Rs m83,7035,811 1,440.4%   
Share capital Rs m1,024167 612.8%   
"Free" reserves Rs m86,42114,248 606.5%   
Net worth Rs m87,44514,416 606.6%   
Long term debt Rs m25,5510-   
Total assets Rs m180,65317,649 1,023.6%  
Interest coverage x26.656.6 47.0%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.70.8 82.3%   
Return on assets %10.68.1 131.9%  
Return on equity %20.99.6 217.4%  
Return on capital %22.013.7 160.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42,6836,164 692.5%   
Fx outflow Rs m11,2421,334 842.5%   
Net fx Rs m31,4414,829 651.0%   
CASH FLOW
From Operations Rs m9,1931,231 747.1%  
From Investments Rs m-9,737-208 4,679.0%  
From Financial Activity Rs m515-595 -86.5%  
Net Cashflow Rs m-29427 -6.8%  

Share Holding

Indian Promoters % 74.8 55.4 135.0%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 8.3 3.4 244.8%  
FIIs % 5.9 3.9 151.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 37.0 29.7%  
Shareholders   44,069 30,437 144.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   NATCO PHARMA  PANACEA BIOTECH  GLENMARK PHARMA  ABBOTT INDIA  PLETHICO PHARMA  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Marginally Lower; IT Stocks Under Pressure(09:30 am)

Asian share markets edged near this year's peak while benchmark US treasury yields, and the dollar dropped after the Federal Reserve signaled possible interest rate cuts later this year.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jun 20, 2019 10:33 AM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - VENUS REMEDIES COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS